Dr Reddy's Laboratories Ltd. (RDY)

Trade RDY now with
4/1/2022 8:05:08 AM Dr. Reddy's Laboratories And MediCane Health Launch Medical Cannabis Products In Germany
12/9/2021 11:48:53 PM Dr. Reddy's Laboratories Launches Venlafaxine ER Tablets In The U.S. Market
12/9/2021 3:37:35 AM Dr. Reddy's Laboratories Launches Valsartan Tablets, USP In The U.S. Market
10/29/2021 9:05:09 AM Dr. Reddy's Labs Announces Launch Of Ephedrine Sulfate Injection USP, 50 Mg/mL, Single-Dose Vial In U.S.
10/19/2021 12:36:48 AM Dr. Reddy's Laboratories Announces Final Approval For Lenalidomide Capsules From U.S. FDA
9/7/2021 7:32:42 AM Citius Buys Dr. Reddy's License For Late-Phase 3 Oncology Immunotherapy For Treatment Of CTCL, Other Cancer Indications
9/4/2021 2:36:05 AM Dr. Reddy's Laboratories Enters Deal With Citius Pharma To Sell Rights To Anti-cancer Agent E7777
9/2/2021 12:13:49 AM Dr. Reddy's Laboratories Canada Announces Launch Of Reddy-Lenalidomide
8/31/2021 2:45:41 AM Dr. Reddy's Laboratories Unveils Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsules, USP In The U.S. Market
8/4/2021 10:36:37 AM Dr. Reddy's To Sell U.S. And Canada Territory Rights For ELYXYB 25 Mg/mL, To BioDelivery Sciences
8/3/2021 8:38:25 AM Dr. Reddy's Unveils Re-Launch Of OTC Naproxen Sodium Tablets USP, 220 Mg, Store-Brand Equivalent Of Aleve, In U.S.